Express Pharma
Express Pharma
Browsing tag
Gilead Sciences
Gilead Sciences announces $4 mn ALL4LIVER grant for viral hepatitis elimination by 2030
Read more
US FDA places partial clinical hold on Gilead’s studies on Magrolimab for AML treatment
Read more
EMA validates Gilead’s Marketing Authorisation Application for Lenacapavir
Read more
China Junshi’s potential COVID drug shows promise in small trial
Read more
Gilead withdraws use of Zydelig to treat cancer
Read more
Gilead submits Biologics Licence Application to USFDA for Bulevirtide
Read more
Gilead Sciences launches Asia Pacific All4LIVER Grant 2021
Read more
India to import 4.5 lakh vials of Remdesivir
Read more
Gilead Sciences to support expansion of local production capacity of Remdesivir in India
Read more
Gilead gets US FDA Accelerated Approval for Trodelvy to treat metastatic urothelial cancer
Read more
Posts navigation
Page 1 of 6
…
Page 6 of 6
Next